ARMO BioSciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ARMO and buy or sell other stocks, ETFs, and their options commission-free!About ARMO
ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki).
CEOPhilip L. Johnson
CEOPhilip L. Johnson
Employees—
Employees—
HeadquartersIndianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded2010
Founded2010
Employees—
Employees—
ARMO Key Statistics
Market cap1.52B
Market cap1.52B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume244.60K
Average volume244.60K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$57.19
52 Week high$57.19
52 Week low$25.10
52 Week low$25.10
Stock Snapshot
With a market cap of 1.52B, ARMO BioSciences(ARMO) trades at $49.98.
On 2026-04-29, ARMO BioSciences(ARMO) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for ARMO BioSciences(ARMO) stock has reached 0, versus its average volume of 244.6K.
The stock's 52-week range extends from a low of $25.10 to a high of $57.19.
The stock's 52-week range extends from a low of $25.10 to a high of $57.19.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.